| 39,795 Euro | +0,673 +1,72 % | ||
| WKN: A0MKX6 ISIN: US92769L1017 Ticker-Symbol: N5T | Frankfurt | 17.05.13 | 15:41 Uhr |
Branche TelekomAktienmarkt NASDAQ-100 |
|
|
DIE FOLGENDE AKTIE IST AB SOFORT AUSGESETZT: THE FOLLOWING SHARE IS SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL Virgin Media N5T US92769l1017 BAW/UFN Stem Stell R5W CA8585721001 BAW/UFN Vuzik Corp. V7X US92921W1027 BAW/UFN Digital China DIN BMG2759B172 BAW/UFN China Vanguard YB2N China Vanguard BAW7UfN
| Zeit | Aktuelle Nachrichten | |
|---|---|---|
| 15.05. | CHINA VANGUARD (08156): Third Quarterly Report 2012/2013 | |
Mehr lesen zu: CHINA VANGUARD (08156): Third Quarterly Report 2012/2013 | ||
| 14.05. | CHINA VANGUARD (08156.HK) loss 5.49M last quarter | |
Mehr lesen zu: CHINA VANGUARD (08156.HK) loss 5.49M last quarter | ||
| 14.05. | CHINA VANGUARD (08156): THIRD QUARTERLY RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 31 MARCH 2013 | |
Mehr lesen zu: CHINA VANGUARD (08156): THIRD QUARTERLY RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 31 MARCH 2013 | ||
| 08.05. | CHINA VANGUARD (08156.HK) expects loss to extend for 9 mth ended Mar | |
Mehr lesen zu: CHINA VANGUARD (08156.HK) expects loss to extend for 9 mth ended Mar | ||
| 08.05. | CHINA VANGUARD (08156): PROFIT WARNING | |
Mehr lesen zu: CHINA VANGUARD (08156): PROFIT WARNING |
| Zeit | Aktuelle Nachrichten | |
|---|---|---|
| 16.05. | Stem Cell Therapeutics reports completion of Phase I study dosing | |
Mehr lesen zu: Stem Cell Therapeutics reports completion of Phase I study dosing | ||
| 16.05. | Stem Cell Therapeutics Corp (2): Stem Cell to begin trading on OTCQX May 20 | |
Mehr lesen zu: Stem Cell Therapeutics Corp (2): Stem Cell to begin trading on OTCQX May 20 | ||
| 16.05. | Stem Cell Therapeutics to Begin Trading on the U.S. OTCQX Marketplace | |
| TORONTO, ONTARIO -- (Marketwired) -- 05/16/13 -- Stem Cell Therapeutics Corp. (TSX VENTURE: SSS), a biopharmaceutical company developing cancer stem cell-related technologies, today announced that... Mehr lesen zu: Stem Cell Therapeutics to Begin Trading on the U.S. OTCQX Marketplace | ||
| 16.05. | Stem Cell Therapeutics Announces Completion of Dosing in Phase I Study of TTI-1612 in Patients With Interstitial Cystitis/Bladder Pain Syndrome | |
| TORONTO, ONTARIO -- (Marketwired) -- 05/16/13 -- Stem Cell Therapeutics Corp. (TSX VENTURE: SSS), a biopharmaceutical company developing cancer stem cell-related technologies, today announced that... Mehr lesen zu: Stem Cell Therapeutics Announces Completion of Dosing in Phase I Study of TTI-1612 in Patients With Interstitial Cystitis/Bladder Pain Syndrome | ||
| 17.04. | Stem Cell Therapeutics Licenses Exclusive Rights to Clinical Cancer Stem Cell Program / Corporate refocusing mission completed | |
| TORONTO, ONTARIO -- (Marketwired) -- 04/17/13 -- Stem Cell Therapeutics Corp. (TSX VENTURE: SSS), a biopharmaceutical company developing cancer stem cell-related technologies, today announced the... Mehr lesen zu: Stem Cell Therapeutics Licenses Exclusive Rights to Clinical Cancer Stem Cell Program / Corporate refocusing mission completed |
| Zeit | Aktuelle Nachrichten | |
|---|---|---|
| 17.05. | Virgin Media Remains Neutral | |
Mehr lesen zu: Virgin Media Remains Neutral | ||
| 16.05. | TalkTalk takes battle to Sky, BT and Virgin Media with TV growth | |
Mehr lesen zu: TalkTalk takes battle to Sky, BT and Virgin Media with TV growth | ||
| 15.05. | Liberty Global Names Robert Dunn CFO, Virgin Media | |
| NEW YORK CITY (dpa-AFX) - Liberty Global Inc. (LBTYA, LBTYB, LBTYK)
announced it will appoint Robert Dunn, currently Managing Director of UPC
Netherlands, to the position of Chief Financial... Mehr lesen zu: Liberty Global Names Robert Dunn CFO, Virgin Media | ||
| 15.05. | BRIEF-Liberty names new Virgin Media CFO | |
Mehr lesen zu: BRIEF-Liberty names new Virgin Media CFO | ||
| 15.05. | Liberty Global Unveils Management Changes At Virgin Media, UPC | |
Mehr lesen zu: Liberty Global Unveils Management Changes At Virgin Media, UPC |
| Zeit | Aktuelle Nachrichten | |
|---|---|---|
| 14.05. | SAP und Vuzix stellen Datenbrille für Profis vor | |
Mehr lesen zu: SAP und Vuzix stellen Datenbrille für Profis vor | ||
| 10.05. | Vuzix Corp (2): Vuzix, Brison work on augmented reality applications | |
Mehr lesen zu: Vuzix Corp (2): Vuzix, Brison work on augmented reality applications | ||
| 10.05. | Vuzix to Unleash the Power of Augmented Reality and Real-Time Data Access at SAP's SAPPHIRE NOW 2013 | |
| NEW YORK, May 10, 2013 /PRNewswire/ --Vuzix Corporation (TSX-V: VZX, OTC:BB: VUZI, FMB: V7X), a leading developer and supplier of smart glasses, today announced that it has been working with Paul... Mehr lesen zu: Vuzix to Unleash the Power of Augmented Reality and Real-Time Data Access at SAP's SAPPHIRE NOW 2013 | ||
| 01.05. | Vuzix Corp (2): Vuzix sells out of M100 smart glasses kits | |
Mehr lesen zu: Vuzix Corp (2): Vuzix sells out of M100 smart glasses kits | ||
| 01.05. | Vuzix Sells Out of Gold Software Developer Kits for New M100 Smart Glasses | |
| NEW YORK, May 1, 2013 /PRNewswire/ --Vuzix Corporation (TSX-V: VZX, OTC:BB: VUZI, FMB: V7X), the leading developer and supplier of smart glasses, announced that driven by strong demand, its initial... Mehr lesen zu: Vuzix Sells Out of Gold Software Developer Kits for New M100 Smart Glasses |
| Aktie | Kurs | % |
|---|---|---|
| CHINA VANGUARD GROUP LTD | 0,022 | 0 % |
| STEM CELL THERAPEUTICS CORP | 0,078 | -2,5 % |
| VIRGIN MEDIA INC | 39,795 | +1,72 % |
| VUZIX CORPORATION | 5,50 | -0,90 % |
